Table 1 Distribution of clinical features in 1144 Pan-Lung Cancer samples
Clinical features | Entire cohort N = 1144 | % |
|---|---|---|
Metastasis class | ||
M0 | 731 | 63.9% |
M1 | 22 | 1.9% |
MX | 210 | 18.4% |
Cancer type | ||
Lung Adenocarcinoma | 660 | 57.7% |
Lung Squamous Cell Carcinoma | 484 | 42.3% |
Tumour stage | ||
Stage I | 8 | 0.7% |
Stage IA | 246 | 21.5% |
Stage IB | 321 | 28.1% |
Stage II | 4 | 0.3% |
Stage IIA | 129 | 11.3% |
Stage IIB | 174 | 15.2% |
Stage III | 3 | 0.3% |
Stage IIIA | 155 | 13.5% |
Stage IIIB | 34 | 3.0% |
Stage IV | 8 | 3.3% |
Age range | ||
< = 60 years | 61 | 29.5% |
> 60 years | 146 | 70.5% |
Gender | ||
Female | 468 | 40.9% |
Male | 673 | 58.8% |
N stage | ||
N0 | 624 | 54.5% |
N1 | 221 | 19.3% |
N2 | 113 | 9.9% |
NX | 16 | 1.4% |
Smoking status | ||
Current reformed smoker for < or = 15 years | 407 | 35.6% |
Current reformed smoker for > 15 years | 212 | 18.5% |
Current reformed smoker, duration not specified | 86 | 7.5% |
Current smoker | 271 | 23.7% |
Lifelong non-smoker | 111 | 9.7% |